Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    scPharmaceuticals Inc.

    NASDAQ: SCPH · Real-Time Price · USD
    3.98
    0.01 (0.25%)
    At close: Jun 26, 2025, 3:59 PM
    4.16
    4.52%
    After-hours: Jun 26, 2025, 05:01 PM EDT

    scPharmaceuticals Statistics

    Share Statistics

    scPharmaceuticals has 52.79M shares outstanding. The number of shares has increased by 39.47% in one year.

    Shares Outstanding

    n/a
    		 52.79M

    Shares Change (YoY)

    n/a
    		 39.47%

    Shares Change (QoQ)

    n/a
    		 0.49%

    Owned by Institutions (%)

    n/a
    		 85.43%

    Shares Floating

    n/a
    		 35.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,625

    FTD / Avg. Volume

    n/a
    		 0.67%

    Short Selling Information

    The latest short interest is 2.08M, so 3.93% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.08M

    Short % of Shares Out

    n/a
    		 3.93%

    Short % of Float

    n/a
    		 4.47%

    Short Ratio (days to cover)

    n/a
    		 4.63

    Valuation Ratios

    The PE ratio is -1.85 and the forward PE ratio is -14.67. scPharmaceuticals's PEG ratio is -0.05.

    PE Ratio

    n/a
    		 -1.85

    Forward PE

    n/a
    		 -14.67

    PS Ratio

    n/a
    		 4.34

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 11.83

    P/FCF Ratio

    n/a
    		 -2.23

    PEG Ratio

    n/a
    		 -0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for scPharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.12, with a Debt / Equity ratio of 3.96.

    Current Ratio

    n/a
    		 7.12

    Quick Ratio

    n/a
    		 6.18

    Debt / Equity

    n/a
    		 3.96

    Debt / EBITDA

    n/a
    		 -0.68

    Debt / FCF

    n/a
    		 -0.75

    Interest Coverage

    n/a
    		 -8.56

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $224,271.6

    Profits Per Employee

    n/a
    		 $-525,604.94

    Employee Count

    n/a
    		 162

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 0.82

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -10.81% in the last 52 weeks. The beta is 0.36, so scPharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.36

    52-Week Price Change

    n/a
    		 -10.81%

    50-Day Moving Average

    n/a
    		 3.21

    200-Day Moving Average

    n/a
    		 3.54

    Relative Strength Index (RSI)

    n/a
    		 60.92

    Average Volume (20 Days)

    n/a
    		 391,017

    Income Statement

    In the last 12 months, scPharmaceuticals had revenue of 36.33M and earned -85.15M in profits. Earnings per share was -1.91.

    Revenue

    n/a
    		 36.33M

    Gross Profit

    n/a
    		 24.97M

    Operating Income

    n/a
    		 -64.78M

    Net Income

    n/a
    		 -85.15M

    EBITDA

    n/a
    		 -77.43M

    EBIT

    n/a
    		 -77.58M

    Earnings Per Share (EPS)

    n/a
    		 -1.91
    Full Income Statement

    Balance Sheet

    The company has 75.66M in cash and 52.69M in debt, giving a net cash position of 22.96M.

    Cash & Cash Equivalents

    n/a
    		 75.66M

    Total Debt

    n/a
    		 52.69M

    Net Cash

    n/a
    		 22.96M

    Retained Earnings

    n/a
    		 -366.49M

    Total Assets

    n/a
    		 90.96M

    Working Capital

    n/a
    		 73.04M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -70.54M and capital expenditures -21K, giving a free cash flow of -70.56M.

    Operating Cash Flow

    n/a
    		 -70.54M

    Capital Expenditures

    n/a
    		 -21K

    Free Cash Flow

    n/a
    		 -70.56M

    FCF Per Share

    n/a
    		 -1.58
    Full Cash Flow Statement

    Margins

    Gross margin is 68.73%, with operating and profit margins of -178.29% and -234.36%.

    Gross Margin

    n/a
    		 68.73%

    Operating Margin

    n/a
    		 -178.29%

    Pretax Margin

    n/a
    		 -234.36%

    Profit Margin

    n/a
    		 -234.36%

    EBITDA Margin

    n/a
    		 -213.12%

    EBIT Margin

    n/a
    		 -178.29%

    FCF Margin

    n/a
    		 -194.21%

    Dividends & Yields

    SCPH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SCPH is $12, which is 203% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 203%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.37

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist